Literature DB >> 17143093

The challenge of managing patients with polyarteritis nodosa.

Mårten Segelmark1, Daina Selga.   

Abstract

PURPOSE OF REVIEW: In this short review we focus on the problems faced by clinicians caused by the changing definitions of polyarteritis nodosa. RECENT
FINDINGS: The term polyarteritis nodosa has been used for more than 100 years as a diagnostic term for patients with systemic vasculitis; however, specific vasculitides have been singled out like branches being chopped off a tree. Now, so little is left of the trunk of that tree that it is questionable to what extent we can trust older literature with respect to clinical features, natural history and response to treatment. Many authors of case reports, as well as authors of reviews and book chapters, claim they adhere to the Chapel Hill Consensus Conference definition of polyarteritis nodosa, yet still cite almost exclusively studies using older definitions without highlighting this dilemma. In the past year, two proposals affecting classification have been published: one stating that cutaneous polyarteritis nodosa and hepatitis-associated polyarteritis nodosa are diseases distinct from classical polyarteritis nodosa, and one providing an algorithm to separate microscopic polyangiitis from classical polyarteritis nodosa.
SUMMARY: There is hope that a wide acceptance of the new classification principles will lead to a more uniform way to diagnose classical polyarteritis nodosa, which will facilitate clinical studies and eventually improve management.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17143093     DOI: 10.1097/BOR.0b013e328011cb6f

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  6 in total

1.  [Therapy of vasculitides: according to recommendations of the European League Against Rheumatism (EULAR) and European Vasculitis Study Group (EUVAS)].

Authors:  J U Holle; F Moosig; W L Gross
Journal:  Internist (Berl)       Date:  2011-06       Impact factor: 0.743

Review 2.  Polyarteritis nodosa presenting as pancytopenia: case report and review of the literature.

Authors:  Leslie R Harrold; Nancy Y N Liu
Journal:  Rheumatol Int       Date:  2008-03-27       Impact factor: 2.631

3.  Sudden death due to polyarteritis nodosa.

Authors:  Lisa B E Shields; Meredith Burge; John C Hunsaker
Journal:  Forensic Sci Med Pathol       Date:  2011-10-08       Impact factor: 2.007

4.  Vasculitic multiplex mononeuritis: polyarteritis nodosa versus cryoglobulinemic vasculitis.

Authors:  Corinna Steidl; Martin W Baumgaertel; Eva Neuen-Jacob; Peter Berlit
Journal:  Rheumatol Int       Date:  2010-04-17       Impact factor: 2.631

5.  [Classification and therapy of vasculitis according to recommendations of the European League Against Rheumatism (EULAR)].

Authors:  J U Holle; T Bley; W L Gross
Journal:  Radiologe       Date:  2010-10       Impact factor: 0.635

6.  Cutaneous polyarteritis nodosa.

Authors:  María Alejandra Matteoda; Paola Cecilia Stefano; Marcela Bocián; María Marta Katsicas; Josefina Sala; Andrea Bettina Cervini
Journal:  An Bras Dermatol       Date:  2015 May-Jun       Impact factor: 1.896

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.